VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price was up 16.7% on Wednesday . The company traded as high as C$0.18 and last traded at C$0.18. Approximately 119,810 shares changed hands during mid-day trading, an increase of 34% from the average daily volume of 89,243 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Price Performance
The company has a debt-to-equity ratio of 217.41, a current ratio of 0.28 and a quick ratio of 6.67. The firm has a market capitalization of C$30.65 million, a P/E ratio of -6.33 and a beta of 0.41. The company’s 50 day moving average price is C$0.19 and its 200 day moving average price is C$0.22.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- What is Forex and How Does it Work?
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- What Does a Stock Split Mean?
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
